New Investor / Latest Resources :: 22nd Century Group, Inc. (XXII)

22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

Below are a few links to help you quickly become familiar with 22nd Century Group.

Investor Presentations

22nd Century Overview
View Presentation

22nd Century Overview of GVB Biopharma Acquisition
View Presentation

Our Hops Franchise and Market Overview
View Presentation

Recent Quarterly Report

Q1 2022 Financial Results

Insights

22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S.
Multiple former FDA Commissioners Voice Support For Reduced Nicotine Mandate; Proposed Legislation Would be Game-Changing for 22nd Century
22nd Century now controls the most comprehensive and innovative upstream cannabinoid value chain in the hemp/cannabis industry
22 Century Enters Global Specialty Hops Market